Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 423
Selected: 0
NCT IDTitle
NCT00002878Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT00110123Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma
NCT05128773Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity
NCT00085059Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma
NCT06978062Peri-operative Treatment of Resectable Gastroesophageal Cancer Using Bemarituzumab (BEMA) Plus Perioperative Treatment
NCT02863055Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma
NCT00002549Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
NCT03319316Combination of Durvalumab and Tremelimumab as Maintenance Treatment in Patients With Non Squamous and Squamous (NSCLC)
NCT00016211Radiation Therapy to Prevent Brain Metastases in Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer
NCT02307604SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial Access
NCT00083096Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas
NCT04708548Long Term Implications of Rare Brain Tumours'
NCT02834884SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
NCT01164189Bevacizumab in Recurrent Grade II and III Glioma
NCT03563040Study of Photopheresis in the Treatment of Erythrodermic MF and SS
NCT00626990Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH)
NCT00956072Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate
NCT00006477Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors
NCT00045019Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care
NCT04031677Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
NCT02234050Trabectedin for Recurrent Grade II/III Meningioma
NCT03437200Combination of Chemoradiation With Immunotherapy in Inoperable œsophageal Cancer
NCT02273271Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative Chemo
NCT04127110Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients
NCT00002503Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases
NCT00003418Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer
NCT00028691Chlorambucil Compared With Radiation Therapy in Treating Patients With Previously Untreated Stage III or Stage IV Follicular Lymphoma
NCT03488810Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer
NCT00079261Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
NCT00003642Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer
NCT00028756Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
NCT04097093Long-term Surival of GIST Patients ≥ 10 Years on Imatinib
NCT00025298Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx
NCT00077116Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
NCT02214134SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access
NCT00003916Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma
NCT00085163Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon
NCT00047125Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
NCT00066378Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer
NCT00003989ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma
NCT00002555High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer
NCT01208064Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy
NCT00014599Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva
NCT00005826Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme
NCT00020826Assessing Quality of Life of Patients With Stomach Cancer
NCT01524926CREATE: Cross-tumoral Phase 2 With Crizotinib
NCT00022620Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer
NCT00003681Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome
NCT00003140Letrozole After Tamoxifen in Treating Women With Breast Cancer
NCT00003803Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed